Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages

Brain

Volumn 119, Issue 5, 1996, Pages 1461-1469

  Hanemann, Clemens O ^a   Gabreëls Festen, Anneke A W M ^b   Müller, Hans W ^a   Stoll, Guido ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell differentiation; CMT1A neuropathy; Immunohistochemistry; Low affinity NGF receptor; PMP22; Schwann cells

Indexed keywords

ANTIBODY; CELL MARKER; CYCLINE; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN PROTEIN; NERVE GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE BIOPSY; NEUROPATHOLOGY; PHENOTYPE; POLYNEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEPTOR AFFINITY; SCHWANN CELL;

ADOLESCENT; ADULT; CHARCOT-MARIE-TOOTH DISEASE; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOHISTOCHEMISTRY; MYELIN PROTEINS; RECEPTORS, NERVE GROWTH FACTOR; SURAL NERVE; TIME FACTORS;

EID: 0029955993     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.5.1461     Document Type: Article

References (39)

1. Anton ES, Weskamp G, Reichardt LF, Matthew WD. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc Natl Acad Sci USA 1994; 91: 2795-9.
2. Chance PF, Bird TD, Matsunami N, Lensch MW, Brothman AR, Feldman GM. Trisomy 17p associated with Charcot-Marie-Tooth neuropathy type 1A phenotype: evidence for gene dosage as a mechanism in CMT1A. Neurology 1992; 42: 2295-9.
3. Connolly KM, Bogdanffy MS. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2′-deoxyuridine. J Histochem Cytochem 1993; 41: 1-6.
4. de Visser M. Diagnostic criteria for autosomal dominant hereditary motor and sensory neuropathy type 1A. Neuromuscul Disord 1993; 3: 77-9.
5. DiStefano PS, Johnson EM Jr. Nerve growth factor receptors on cultured rat Schwann cells. J Neurosci 1988; 8: 231-41.
6. Fan X, Gelman BB. Schwann cell nerve growth factor receptor expression during initiation of remyelination. J Neurosci Res 1992; 31: 58-67.
7. Fischbeck KH. Charcot-Marie-Tooth disease type 1A, 9 November 1992, San Francisco, CA, USA. Neuromuscul Disord 1993; 3: 81-2.
8. Gabreëls-Festen AAWM, Joosten EMG, Gabreëls FJM, Jennekens FGI, Janssen-van Kempen TW. Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type 1). J Neurol Sci 1992; 107: 145-54.
9. Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, van Broeckhoven C, et al. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1A sural nerve biopsies. J Neurosci Res 1994; 37: 654-9.
10. Hanemann CO, Stoll G, Müller HW. PMP22 expression in CMT1A neuropathy [letter; comment]. Ann Neurol 1995; 37: 136. Comment on: Ann Neurol 1994; 35: 445-50.
11. Hanemann CO, Stoll G, Müller HW. PMP22 expression in CMT1A neuropathy [letter; comment]. Ann Neurol 1995; 37: 136. Comment on: Ann Neurol 1994; 35: 445-50.
12. Harding AE. From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. [Review], Brain 1995; 118: 809-18.
13. Heumann R, Lindholm D, Bandtlow C, Meyer M, Radeke MJ, Misko TP, et al. Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages. Proc Natl Acad Sci USA 1987; 84: 8735-9.
14. Hoogendijk JE, Hensels GW, Gabreëls-Festen AAWM, Gabreëls FJ, Janssen EA, de Jonghe P, et al. De-novo mutation in hereditary motor and sensory neuropathy type 1. Lancet 1992; 339: 1081-2.
15. Jessen KR, Mirsky R. Schwann cell precursors and their development. [Review]. Glia 1991; 4: 185-94.
16. Jessen KR, Thorpe R, Mirsky R. Molecular identity, distribution and heterogeneity of glial fibrillary acidic protein: an immunoblotting and immunohistochemical study of Schwann cells, satellite cells, enteric glia and astrocytes. J Neurocytol 1984; 13: 187-200.
17. Jessen KR, Morgan L, Stewart HJS, Mirsky R. Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: development and regulation by neuron-Schwann cell interactions. Development 1990; 109: 91-103.
18. Killian JM, Kloepfer HW. Homozygous expression of a dominant gene for Charcot-Marie-Tooth Neuropathy. Ann Neurol 1979; 5: 515-22.
19. Lemke G. The molecular genetics of myelination: an update. [Review]. Glia 1993; 7: 263-71.
20. Lupski JR, Wise CA, Kuwano A, Pentao L, Parke JT, Glaze DG, et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A, Nat Genet 1992; 1: 29-33.
21. Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth IA. Nat Genet 1992; 1: 176-9.
22. Nelis E, Van Broeckhoven C, De Jonghe P, Löfgren A, Vandenberghe A, Latour P, et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 (CMT1) and hereditary neuropathy with liability to pressure palsies (HNPP): a European collaborative study. Eur J Hum Genet 1996; 4: 25-33.
23. Ouvrier RA, McLeod JG, Conchin TE. The hypertrophic forms of hereditary motor and sensory neuropathy. A study of hypertrophic Charcot-Marie-Tooth disease (HMSN type I) and Dejerine-Sottas disease (HMSN type III) in childhood Brain 1987; 110: 121-48.
24. Patel PI, Lupski JR. Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease. [Review]. Trends Genet 1994; 10: 128-33.
25. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992; 1: 159-65.
26. Scarpini E, Ross AH, Rosen JL, Brown MJ, Rostami A, Koprowski H, et al. Expression of nerve growth factor receptor during human peripheral nerve development. Dev Biol 1988; 125: 301-10.
27. Sobue G, Yasuda T, Mitsuma T, Ross AH, Pleasure D. Expression of nerve growth factor receptor in human peripheral neuropathies. Ann Neurol 1988; 24: 64-72.
28. Spreyer P, Kuhn G, Hanemann CO, Gillen C, Schaal H, Kuhn R, et al. Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene. EMBO J 1991; 10: 3661-8.
29. Stoll G, Li CY, Trapp BD, Griffin JW. Expression of NGF-receptors during immune-mediated and lysolecithin-induced demyelination of the peripheral nervous system. J Neurocytol 1993; 22: 1022-9.
30. Taniuchi M, Clark HB, Johnson EM Jr. Induction of nerve growth factor receptor in Schwann cells after axotomy. Proc Natl Acad Sci USA 1986; 83: 4094-8.
31. Taniuchi M, Clark HB, Schweitzer JB, Johnson EM Jr. Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties. J Neurosci 1988; 8: 664-81.
32. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication [published erratum appears in Nat Genet 1992; 2: 84]. Nat Genet 1992; 1: 171-5.
33. Toews AD, Griffiths IR, Kyriakidis E, Goodrum JF, Eckermann CE, Morell P, et al. Primary demyelination induced by exposure to tellerium alters Schwann cell gene expression: a model for intracellular targeting of NGF receptor. J Neurosci 1992; 12: 3676-87.
34. Valentijn LJ, Bolhuis PA, Zorn I, Hoogendijk JE, van den Bosch N, Hensels GW, et al. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nate Genet 1992; 1: 166-70.
35. Yasuda T, Sobue G, Mokuno K, Kreider B, Pleasure D. Cultured rat Schwann cells express low affinity receptors for nerve growth factor. Brain Res 1987; 436: 113-19.
36. Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Himoro M, Hayasaka K, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A [see comments]. Ann Neurol 1994; 35: 445-50. Comment in: Ann Neurol 1994; 36: 451-2 , Comment in: Ann Neurol 1995; 37: 136.
37. Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Himoro M, Hayasaka K, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A [see comments]. Ann Neurol 1994; 35: 445-50. Comment in: Ann Neurol 1994; 36: 451-2 , Comment in: Ann Neurol 1995; 37: 136.
38. Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Himoro M, Hayasaka K, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A [see comments]. Ann Neurol 1994; 35: 445-50. Comment in: Ann Neurol 1994; 36: 451-2 , Comment in: Ann Neurol 1995; 37: 136.
39. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Müller HW. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J 1995; 14: 1122-8.